GlaxoSmithKline Vaccine Unlikely To Receive US Approval For 2 Years London-The new cervical cancer vaccine that has been submitted by GlaxosmithKline for approval in the United States is not likely to receive the go ahead until 2010 at the earliest. The company has released a new timetable that sets its expectant date for approval of its new Cervarix Cancer Vaccine at 2010 at the earliest. Read More
Cure Worked On Mice To Receive Testing On People Winston-Salem NC- Beginning this week at Wake Forest University an exciting potential therapy that has cured cancer in mice will start human testing. In the last 2 years there have been several mice that have been cured, and the testing has received approval from the federal Food and Drug Administration to begin human trials. The Cancer therapy involves transfusion of white blood cells into the body of cancer patients. Read More
Seattle, WA-One of the more difficult types of cancer to detect reliably is women’s ovarian cancer. Now, a new study suggests that over 80 percent of the time this type of cancer can be reliably detected in its early stages by early stage symptoms, plus a blood test. Many women have complained that they have regular checkups, but then later are told that they have ovarian cancer, and they feel like they should have been diagnosed earlier. Finally a member of the medical community listened. ... Read More
-
